Novo Nordisk to invest $1.2bn in new rare disease drug plant in Denmark

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new plant in Odense, Denmark, to produce drugs for rare diseases, it said on Monday.  

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO